Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Exopharm Ltd logo — Delivering Transformative Medicines

Exopharm Ltd

Delivering Transformative Medicines

Founded 2013 Australia Melbourne, Australia 5 employees Biopharma, Biotechnology

General Information

Company Name Exopharm Ltd
Founded Year 2013
Location Australia Melbourne, Australia +2
Founders / Decision Makers
Team member
Employees 5
Industries Biopharma, Biotechnology
Social

Get notified when Exopharm Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Exopharm Ltd

Exopharm Ltd is a leading player in exosome technology, with a focus on delivering transformative medicines. The company, traded as ASX:EX1, boasts an extensive portfolio of intellectual property and know-how related to exosomes and their manufacture. Exosomes, which hold potential as an alternative means of drug delivery within the body, address critical needs for the success of exosome medicines. These include LEAP manufacturing technology, LOAD API loading technologies, and EVPS tropism technologies. By harnessing exosome-delivery, the company aims to enhance the treatment of various chronic or inherited medical conditions. Established in 2013, Exopharm operates within the Biopharma and Biotechnology sectors. It is currently making its proprietary technologies available to pharmaceutical and biotechnology firms seeking to leverage exosome-delivery for their own products.

Taxonomy: exosome technology, drug delivery, manufacturing technology, regenerative medicine, biopharmaceuticals, therapeutic agents, intellectual property, extracellular vesicles, cell engineering, affinity chromatography

No funding data available for Exopharm Ltd yet.

Get notified when Exopharm Ltd raises funding

Exopharm Ltd Alternatives & Competitors

Exopharm Ltd vs
Mantra Bio
Mantra Bio United States

Mantra Bio is harnessing exosomes to deliver safe, highly targeted medicines.

Series A
14 employees
Biotechnology, Life Sciences
Exopharm Ltd vs
Codiak Biosciences
Codiak Biosciences

Codiak is a clinical-stage biopharmaceutical company focused on developing exosome-based therapeutic...

Post Ipo Equity
Biotechnology, Health and Wellness
Exopharm Ltd vs
ReNeuron Group Plc
ReNeuron Group Plc United Kingdom

Developing the next generation of Engineered Exosomes.

Post Ipo Equity
27 employees
Biotechnology, Health Care

FAQ About Exopharm Ltd

Delivering Transformative Medicines
Exopharm Ltd was founded in 2013.
Exopharm Ltd is headquartered in Melbourne, Australia.
Exopharm Ltd operates in the following industries: Biopharma, Biotechnology.
Exopharm Ltd has approximately 5 employees.
Top alternatives and competitors to Exopharm Ltd include Mantra Bio, Codiak Biosciences, ReNeuron Group Plc, ExoCoBio, Exosome Diagnostics, a Bio-Techne brand. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Exopharm Ltd and Mantra Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Exopharm Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy